Investigational weight-loss drug trial shows average reduced body weight of 30%

According to results published by manufacturer Eli Lilly, participants taking 12mg of retatrutide lost an average of 28.7% of their body weight at 68 weeks, while patients taking placebo lost 2.1%.…